Zoticon has invested over $100 million to date in promising phase III therapeutics including two oncology products and a cardiovascular combination product. Our investors represent solid financial institutions who share our passion and commitment in bringing new drugs to patients.

Zoticon creates a new company for each in-licensed late stage asset, assuring that every drug that is licensed by us receives focused developmental effort. We have the necessary qualities for a successful partnering: creativity, commitment, flexibility, experience and above all, integrity. We are supported by a strong technological, business and financial infrastructure. Our team prides itself on honesty and integrity. Our motives are not based solely on maximizing profits, and we are enthusiastic about bringing new therapies to patients. The Zoticon team is composed of seasoned entrepreneurs and investment bankers that can move quickly and decisively throughout the transaction. While a smooth transaction is clearly important, our operational teams in our portfolio companies are equally imbued with the Zoticon “Vital Spirit”. Zoticon portfolio companies are able to complete trials faster and more efficiently because that is their sole focus.

FOCUS
Your product can not end up on the back burner.
Zoticon’s Special Purpose Vehicle business model assures that your product gets the attention it deserves. Unlike larger pharmaceutical companies, each Zoticon portfolio company is predicated entirely on the continued clinical development of the in-licensed compound. This structure avoids the unfortunate "shifting of priorities" that occurs all too often at larger pharmaceutical companies. To Zoticon portfolio companies, your product is their only priority.

SPEED
We make decisions faster.
Zoticon is committed to making careful but timely decisions faster than other financial or strategic partners. While we are very selective in our investments, the entire process can be done quickly as a result of our highly focused business model, management expertise, industry knowledge and access to funds. You are always dealing with the decision makers as the diligence is completed and transaction memorialized. We work closely with the prospective licensor to make sure we make our investment decisions in time to meet Company's deadlines.

CLINICAL TRIAL EXPERTISE
Your product will reach the market faster.
Zoticon management has extensive experience in clinical trial design and execution. It is in a unique position to assist its portfolio companies obtain approval faster and more efficiently.